Hepatitis C virus therapies: current treatments, targets and future perspectives.
about
Zebrafish as a potential model organism for drug test against hepatitis C virusHigh-throughput screening of low molecular weight NS3-NS4A protease inhibitors using a fluorescence resonance energy transfer substrate.MicroRNA-27a modulates HCV infection in differentiated hepatocyte-like cells from adipose tissue-derived mesenchymal stem cells.Protective effects of quercetin on liver injury induced by ethanol.Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay.Hepatitis C virus network based classification of hepatocellular cirrhosis and carcinomaLittle evidence of bone marrow-derived hepatocytes in the replacement of injured liver.Seroprevalence of hepatitis B and C genotypes among young apparently healthy females of karachi-pakistan.Mechanisms of hepatitis C virus infection.Tight binding enantiomers of pre-clinical drug candidates.Involvement of a bovine viral diarrhea virus NS5B locus in virion assembly.Synthesis and cytotoxic activity of novel 5-substituted-1-(β-L-arabinofuranosyl) pyrimidine nucleosides.QSAR study of HCV NS5B polymerase inhibitors using the genetic algorithm-multiple linear regression (GA-MLR).2'-C-Methyl branched pyrimidine ribonucleoside analogues: potent inhibitors of RNA virus replication.Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes.Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors.Effects of Silymarin, Glycyrrhizin, and Oxymatrine on the Pharmacokinetics of Ribavirin and Its Major Metabolite in Rats.A relaxed discrimination of 2'-O-methyl-GTP relative to GTP between de novo and Elongative RNA synthesis by the hepatitis C RNA-dependent RNA polymerase NS5B.Syntheses and bio-activities of the L-enantiomers of two potent transition state analogue inhibitors of purine nucleoside phosphorylases.Inhibitory effect of Yunnan traditional medicines on hepatitis C viral polymerase.Treatment of chronic hepatitis C in non-responsive patients with pegylated interferon associated with ribavirin and thalidomide: report of six cases of total remission.
P2860
Q28476465-D66E99F1-C264-401E-AC96-BBD82592AB9FQ33228537-043B946B-96EF-426A-B4F2-B6EE34949B74Q33604440-13DF57D6-8A1F-44EF-8A70-283F4ECF6C42Q33975060-CAA96C8D-EFD6-4F1B-B4B4-A8A4F819FB87Q34112325-08FA1FD4-075C-44E5-8B14-EEC75E9C6ADAQ34228398-EB0DB97A-A9D1-458B-AE65-8C770DC276FCQ34582199-6E2ADD44-97B0-4E3C-8C02-48B4F8C4492BQ34780072-C8DBF0BD-90A5-4589-9D77-777D0A2D2B30Q35669529-FD7F8565-B410-4FC1-B369-B1553D9614CFQ36052612-79389F4F-B6B0-4386-806A-48EBCBD6890BQ37492821-FF5BFBB2-DC4A-45FA-AECD-1BB13407E2A6Q39339936-603B225D-E15F-463D-A49E-20A12FA55AF7Q39899194-F7F03A31-56F7-49F6-A000-812DE1844E47Q40073976-793D6154-800B-413A-8C99-899EF2879FFCQ40325245-7C261314-4EF1-445A-9508-4743D0282A7BQ40458972-4ACF6734-E3CC-4BDD-AB61-95E3E40F2BBFQ40747990-D5DD99D9-614C-4416-9B1B-36680922C462Q40821539-386F258D-4396-4459-8261-07B98FC7B742Q42989056-BC6573FF-950A-4664-92E7-81B6ABAB2296Q46981688-6F726B6D-7D34-4A60-BDEB-E5D5E03B4AB6Q50050628-03915B4C-ADA3-4B97-ABD3-917494A81E0FQ50576318-AFA63A80-D9C8-4B2F-9B87-20E121D076B3
P2860
Hepatitis C virus therapies: current treatments, targets and future perspectives.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatitis C virus therapies: current treatments, targets and future perspectives.
@ast
Hepatitis C virus therapies: current treatments, targets and future perspectives.
@en
type
label
Hepatitis C virus therapies: current treatments, targets and future perspectives.
@ast
Hepatitis C virus therapies: current treatments, targets and future perspectives.
@en
prefLabel
Hepatitis C virus therapies: current treatments, targets and future perspectives.
@ast
Hepatitis C virus therapies: current treatments, targets and future perspectives.
@en
P2093
P2860
P1476
Hepatitis C virus therapies: current treatments, targets and future perspectives.
@en
P2093
Johnson Y N Lau
Michelle P Walker
Todd C Appleby
Weidong Zhong
P2860
P356
10.1177/095632020301400101
P577
2003-01-01T00:00:00Z